According to Merus's latest financial reports the company has $0.35 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.35 B | 22.1% |
2022-12-31 | $0.29 B | -29.29% |
2021-12-31 | $0.41 B | 97.55% |
2020-12-31 | $0.20 B | -13.35% |
2019-12-31 | $0.23 B | -10.95% |
2018-12-31 | $0.26 B | 1.75% |
2017-12-31 | $0.26 B | 319.91% |
2016-12-31 | $63.01 M | 60.46% |
2015-12-31 | $39.27 M | 1593.47% |
2014-12-31 | $2.31 M | -88.58% |
2013-12-31 | $20.3 M | 96.3% |
2012-12-31 | $10.34 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -41.25% | ๐บ๐ธ USA |